Truist maintains Buy on Protagonist Therapeutics with $60 target
Truist Securities reiterated its Buy rating and $60.00 price target for Protagonist Therapeutics (NASDAQ:PTGX) shares, which currently trade at $38.78 with a market capitalization of $2.3 billion. The ...
Sampan20 分钟
Developing Chinatown’s Future: A Conversation With ACDC’s Executive Director, Angie Liou
Walking through Chinatown today, you will encounter layers of its identity: the memories of a Chinatown long gone, the visions of a Chinatown that could have been, the Chinatown that remains a home ...